Ceramide in apoptotic signaling and anticancer therapy
- PMID: 16787207
- DOI: 10.2174/092986706777441986
Ceramide in apoptotic signaling and anticancer therapy
Abstract
Ceramide, a product of sphingolipid metabolism, is generated in response to various stress stimuli, such as tumor necrosis factor-alpha, CD95/Fas, chemotherapeutic agents, and irradiation. Ceramide may modulate the biochemical and cellular processes that lead to apoptosis. However, the mechanisms by which ceramide regulates apoptotic events are not fully defined. It is believed that the biological effect of ceramide depends on its concentration, the activation or differentiation status of the cell, and the time frame of action. Here, we discuss the metabolism and cell apoptotic signaling of ceramide. The involvement of protein kinases (i.e. PI3K/Akt and GSK-3beta) and protein phosphatases (i.e. PP1 and PP2A), Bcl-2 family proteins, mitochondrial damage, and caspase cascade activation are demonstrated. Further, ceramide and its derivatives have recently been incorporated into strategies for anticancer therapies. An understanding of the apoptotic signaling pathways mediated by ceramide may shed light on its potential for therapeutic intervention.
Similar articles
-
GSK-3beta acts downstream of PP2A and the PI 3-kinase-Akt pathway, and upstream of caspase-2 in ceramide-induced mitochondrial apoptosis.J Cell Sci. 2007 Aug 15;120(Pt 16):2935-43. doi: 10.1242/jcs.03473. Epub 2007 Jul 31. J Cell Sci. 2007. PMID: 17666435
-
Ceramide regulates cellular homeostasis via diverse stress signaling pathways.Leukemia. 2001 Aug;15(8):1153-60. doi: 10.1038/sj.leu.2402197. Leukemia. 2001. PMID: 11480555 Review.
-
Intracellular signal transduction pathways activated by ceramide and its metabolites.Pharmacol Res. 2003 May;47(5):383-92. doi: 10.1016/s1043-6618(03)00050-1. Pharmacol Res. 2003. PMID: 12676512 Review.
-
The role of ceramide in the cellular response to cytotoxic agents.Curr Opin Oncol. 1998 Nov;10(6):552-9. doi: 10.1097/00001622-199811000-00013. Curr Opin Oncol. 1998. PMID: 9818235 Review.
-
Novel mechanisms of action of classical chemotherapeutic agents on sphingolipid pathways.Biol Chem. 2015 Jun;396(6-7):669-79. doi: 10.1515/hsz-2014-0302. Biol Chem. 2015. PMID: 25719313 Review.
Cited by
-
Targeting sphingosine kinase 1/2 by a novel dual inhibitor SKI-349 suppresses non-small cell lung cancer cell growth.Cell Death Dis. 2022 Jul 12;13(7):602. doi: 10.1038/s41419-022-05049-4. Cell Death Dis. 2022. PMID: 35831279 Free PMC article.
-
Glycogen Synthase Kinase-3β and Caspase-2 Mediate Ceramide- and Etoposide-Induced Apoptosis by Regulating the Lysosomal-Mitochondrial Axis.PLoS One. 2016 Jan 4;11(1):e0145460. doi: 10.1371/journal.pone.0145460. eCollection 2016. PLoS One. 2016. PMID: 26727221 Free PMC article.
-
Targeting sphingosine kinase 2 (SphK2) by ABC294640 inhibits colorectal cancer cell growth in vitro and in vivo.J Exp Clin Cancer Res. 2015 Sep 4;34(1):94. doi: 10.1186/s13046-015-0205-y. J Exp Clin Cancer Res. 2015. PMID: 26337959 Free PMC article.
-
Inhibition of human tumour prostate PC-3 cell growth by cannabinoids R(+)-Methanandamide and JWH-015: involvement of CB2.Br J Cancer. 2009 Sep 15;101(6):940-50. doi: 10.1038/sj.bjc.6605248. Epub 2009 Aug 18. Br J Cancer. 2009. PMID: 19690545 Free PMC article.
-
Apoptotic sphingolipid ceramide in cancer therapy.J Lipids. 2011;2011:565316. doi: 10.1155/2011/565316. Epub 2011 Jan 13. J Lipids. 2011. PMID: 21490804 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous